-
公开(公告)号：US20240181241A1
公开(公告)日：2024-06-06
申请号：US18528599
申请日：2023-12-04
申请人： Aria CV, Inc.
发明人： Karl VOLLMERS , Lynn ZWIERS , John GAINOR , John SCANDURRA
IPC分类号： A61M60/869 , A61B17/00 , A61B17/12 , A61M1/00 , A61M29/02 , A61M60/00 , A61M60/122 , A61M60/135 , A61M60/268 , A61M60/274 , C01B17/00 , C01B17/45
CPC分类号： A61M60/869 , A61B17/12022 , A61B17/12027 , A61B17/12036 , A61B17/12109 , A61B17/12131 , A61B17/12136 , A61M1/00 , A61M29/02 , A61M60/00 , A61M60/122 , A61M60/135 , A61M60/268 , A61M60/274 , C01B17/00 , C01B17/45 , C01B17/4507 , C01B17/4515 , C01B17/453 , A61B2017/00535 , A61B2017/00557 , A61M2202/0208 , A61M2202/0225 , A61M2202/025 , A61M2202/04
摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.
-
公开(公告)号：US11833343B2
公开(公告)日：2023-12-05
申请号：US17496719
申请日：2021-10-07
申请人： Aria CV, Inc.
发明人： Karl Vollmers , Lynn Zwiers , John Gainor , John Scandurra
IPC分类号： A61M60/869 , A61M60/268 , A61M60/122 , A61M60/135 , A61M60/00 , A61M60/274 , A61B17/12 , A61M1/00 , A61M29/02 , C01B17/00 , C01B17/45 , A61B17/00
CPC分类号： A61M60/869 , A61B17/12022 , A61B17/12027 , A61B17/12036 , A61B17/12109 , A61B17/12131 , A61B17/12136 , A61M1/00 , A61M29/02 , A61M60/00 , A61M60/122 , A61M60/135 , A61M60/268 , A61M60/274 , C01B17/00 , C01B17/45 , C01B17/453 , C01B17/4507 , C01B17/4515 , A61B2017/00535 , A61B2017/00557 , A61M2202/025 , A61M2202/0208 , A61M2202/0225 , A61M2202/04
摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.
-
公开(公告)号：US11141581B2
公开(公告)日：2021-10-12
申请号：US17011870
申请日：2020-09-03
申请人： Aria CV, Inc.
发明人： Karl Vollmers , Lynn Zwiers , John Gainor , John Scandurra
IPC分类号： A61M60/869 , A61M60/268 , A61M60/122 , A61M60/135 , A61M60/00 , A61M60/274 , A61B17/12 , A61M1/00 , A61M29/02 , C01B17/00 , C01B17/45 , A61B17/00
摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.
-
公开(公告)号：US20200368507A1
公开(公告)日：2020-11-26
申请号：US16989830
申请日：2020-08-10
申请人： Aria CV, Inc.
发明人： John SCANDURRA , Karl VOLLMERS
摘要： A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
公开(公告)号：US10702682B2
公开(公告)日：2020-07-07
申请号：US16288088
申请日：2019-02-27
申请人： Aria CV, Inc.
发明人： John Scandurra , Karl Vollmers
摘要： A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
公开(公告)号：US20200046369A1
公开(公告)日：2020-02-13
申请号：US16342968
申请日：2017-10-17
申请人： Aria CV, Inc.
摘要： A device for reducing pulsatile pressure within a vessel to treat heart disease, such as pulmonary hypertension, includes a compliant body structured to expand and contract upon changes in pressure within the vessel, a reservoir structured for holding a fluid therein, and a conduit extending between and fluidly coupling the reservoir and the compliant body, wherein the device includes a graphene-polymer composite designed to resist diffusion of the fluid through the device.
-
公开(公告)号：US09242082B2
公开(公告)日：2016-01-26
申请号：US14710180
申请日：2015-05-12
申请人： Aria CV, Inc.
发明人： Karl Vollmers , John Scandurra
CPC分类号： A61M1/1086 , A61B17/12036 , A61B17/1204 , A61B17/12136 , A61B2017/00022 , A61B2017/00212 , A61B2017/00221 , A61B2090/064 , A61M1/1044 , A61M1/1072 , A61M1/125 , A61M5/1723 , A61M5/5086 , A61M25/04 , A61M25/0662 , A61M25/104 , A61M29/02 , A61M39/0208 , A61M2025/0681 , A61M2205/04 , A61M2205/18 , A61M2205/3324 , A61M2205/3327 , A61M2205/3334 , A61M2205/3368 , A61M2205/3389 , A61M2205/3515 , A61M2205/3523 , A61M2205/505 , A61M2210/12 , A61M2230/04
摘要： A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
-
公开(公告)号：US20230091728A1
公开(公告)日：2023-03-23
申请号：US18058255
申请日：2022-11-22
申请人： Aria CV, Inc.
发明人： Karl VOLLMERS , John SCANDURRA
IPC分类号： A61M25/10 , A61M39/02 , A61M5/172 , A61B17/12 , A61M60/135 , A61M60/869 , A61M60/585 , A61M60/523 , A61M60/295 , A61M60/538 , A61M60/515 , A61M5/50 , A61M25/04 , A61M25/06 , A61M29/02
摘要： A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
-
公开(公告)号：US11511089B2
公开(公告)日：2022-11-29
申请号：US16900794
申请日：2020-06-12
申请人： Aria CV, Inc.
发明人： Karl Vollmers , John Scandurra
IPC分类号： A61M25/10 , A61M39/02 , A61M5/172 , A61B17/12 , A61M60/135 , A61M60/869 , A61M60/585 , A61M60/523 , A61M60/295 , A61M60/538 , A61M60/515 , A61M5/50 , A61M25/04 , A61M25/06 , A61M29/02 , A61B17/00 , A61B90/00
摘要： A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e.g., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and the reservoir is adapted to be implanted subcutaneously. The external components may include a clinical controller component, monitoring software configured to run a clinician's computer, a patient monitoring device, and a mobile application configured to run on a patient's mobile device.
-
公开(公告)号：US11406803B2
公开(公告)日：2022-08-09
申请号：US16989830
申请日：2020-08-10
申请人： Aria CV, Inc.
发明人： John Scandurra , Karl Vollmers
IPC分类号： A61M25/10 , A61M29/02 , A61M25/04 , A61M60/135 , A61M60/405 , A61M60/869 , A61M60/17 , A61M60/40 , A61M60/50 , A61M60/122 , A61M60/274 , A61M60/562 , A61M60/857
摘要： A device for reducing pressure within a lumen includes a reservoir structured for holding a fluid therein, an injection port in fluid communication with the reservoir, a compliant body structured to expand and contract upon changes in pressure, and a conduit extending between and fluidly coupling the reservoir and the compliant body. The fluid may be a compressible or a noncompressible fluid.
-
-
-
-
-
-
-
-
-
搜索结果
36 条记录 (耗时 0.029 秒)
